Literature DB >> 21815811

The top five "game changers" in vaccinology: toward rational and directed vaccine development.

Richard B Kennedy1, Gregory A Poland.   

Abstract

Despite the tremendous success of the classical "isolate, inactivate, and inject" approach to vaccine development, new breakthroughs in vaccine research are increasingly reliant on novel approaches that incorporate cutting edge technology and advances in innate and adaptive immunology, microbiology, virology, pathogen biology, genetics, bioinformatics, and many other disciplines in order to: (1) deepen our understanding of the key biological processes that lead to protective immunity, (2) observe vaccine responses on a global, systems level, and (3) directly apply the new knowledge gained to the development of next-generation vaccines with improved safety profiles, enhanced efficacy, and even targeted utility in select populations. Here we highlight five key components foundational to vaccinomics efforts: applied immunogenomics, next generation sequencing and other cutting-edge "omics" technologies, advanced bioinformatics and analysis techniques, and finally, systems biology applied to immune profiling and vaccine responses. We believe these "game changers" will play a critical role in moving us toward the rational and directed development of new vaccines in the 21st century.

Mesh:

Substances:

Year:  2011        PMID: 21815811      PMCID: PMC3166183          DOI: 10.1089/omi.2011.0012

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  42 in total

Review 1.  Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.

Authors:  G A Poland; I G Ovsyannikova; R M Jacobson; D I Smith
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

2.  Is systems biology the key to preventing the next pandemic?

Authors:  Jennifer R Tisoncik; Sarah E Belisle; Deborah L Diamond; Marcus J Korth; Michael G Katze
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

3.  Identification of a universal Group B streptococcus vaccine by multiple genome screen.

Authors:  Domenico Maione; Immaculada Margarit; Cira D Rinaudo; Vega Masignani; Marirosa Mora; Maria Scarselli; Hervé Tettelin; Cecilia Brettoni; Emilia T Iacobini; Roberto Rosini; Nunzio D'Agostino; Lisa Miorin; Scilla Buccato; Massimo Mariani; Giuliano Galli; Renzo Nogarotto; Vincenzo Nardi-Dei; Vincenzo Nardi Dei; Filipo Vegni; Claire Fraser; Giuseppe Mancuso; Giuseppe Teti; Lawrence C Madoff; Lawrence C Paoletti; Rino Rappuoli; Dennis L Kasper; John L Telford; Guido Grandi
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

4.  Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology.

Authors:  Gregory A Poland; Ann L Oberg
Journal:  Vaccine       Date:  2010-04-30       Impact factor: 3.641

Review 5.  Immunoinformatics and systems biology methods for personalized medicine.

Authors:  Qing Yan
Journal:  Methods Mol Biol       Date:  2010

Review 6.  Computational solutions to large-scale data management and analysis.

Authors:  Eric E Schadt; Michael D Linderman; Jon Sorenson; Lawrence Lee; Garry P Nolan
Journal:  Nat Rev Genet       Date:  2010-09       Impact factor: 53.242

Review 7.  Systems vaccinology.

Authors:  Bali Pulendran; Shuzhao Li; Helder I Nakaya
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.

Authors:  Ji-Hoon Cho; Richard Gelinas; Kai Wang; Alton Etheridge; Melissa G Piper; Kara Batte; Duaa Dakhallah; Jennifer Price; Dan Bornman; Shile Zhang; Clay Marsh; David Galas
Journal:  BMC Med Genomics       Date:  2011-01-17       Impact factor: 3.063

10.  InnateDB: facilitating systems-level analyses of the mammalian innate immune response.

Authors:  David J Lynn; Geoffrey L Winsor; Calvin Chan; Nicolas Richard; Matthew R Laird; Aaron Barsky; Jennifer L Gardy; Fiona M Roche; Timothy H W Chan; Naisha Shah; Raymond Lo; Misbah Naseer; Jaimmie Que; Melissa Yau; Michael Acab; Dan Tulpan; Matthew D Whiteside; Avinash Chikatamarla; Bernadette Mah; Tamara Munzner; Karsten Hokamp; Robert E W Hancock; Fiona S L Brinkman
Journal:  Mol Syst Biol       Date:  2008-09-02       Impact factor: 11.429

View more
  20 in total

1.  The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.

Authors:  Richard B Kennedy; Whitney L Simon; Michael J Gibson; Krista M Goergen; Diane E Grill; Ann L Oberg; Gregory A Poland
Journal:  Immunology       Date:  2016-05-17       Impact factor: 7.397

Review 2.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 3.  Leptin-based adjuvants: an innovative approach to improve vaccine response.

Authors:  Sarah J White; Matthew J Taylor; Ryan T Hurt; Michael D Jensen; Gregory A Poland
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

Review 4.  The future of human DNA vaccines.

Authors:  Lei Li; Fadi Saade; Nikolai Petrovsky
Journal:  J Biotechnol       Date:  2012-09-07       Impact factor: 3.307

5.  Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing.

Authors:  Andrew Beck; Robert B Tesh; Thomas G Wood; Steven G Widen; Kate D Ryman; Alan D T Barrett
Journal:  J Infect Dis       Date:  2013-10-17       Impact factor: 5.226

Review 6.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

Review 7.  Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

Authors:  Gregory A Poland; Richard B Kennedy; Brett A McKinney; Inna G Ovsyannikova; Nathaniel D Lambert; Robert M Jacobson; Ann L Oberg
Journal:  Semin Immunol       Date:  2013-06-05       Impact factor: 11.130

Review 8.  Molecular mechanisms for enhanced DNA vaccine immunogenicity.

Authors:  Lei Li; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2015-12-28       Impact factor: 5.217

Review 9.  Enhancing vaccine safety capacity globally: A lifecycle perspective.

Authors:  Robert T Chen; Tom T Shimabukuro; David B Martin; Patrick L F Zuber; Daniel M Weibel; Miriam Sturkenboom
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

10.  Structural and immunological characterization of an epitope within the PAN motif of ectodomain I in Babesia bovis apical membrane antigen 1 for vaccine development.

Authors:  Amarin Rittipornlertrak; Boondarika Nambooppha; Anucha Muenthaisong; Veerasak Punyapornwithaya; Saruda Tiwananthagorn; Yang-Tsung Chung; Bumduuren Tuvshintulga; Thillaiampalam Sivakumar; Naoaki Yokoyama; Nattawooti Sthitmatee
Journal:  PeerJ       Date:  2021-07-16       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.